About the Journal

About the Journal

About ASIDE Cardiovascular

Vision and Mission

ASIDE Cardiovascular is a peer-reviewed, open-access journal committed to advancing diversity, equity, inclusion, and accessibility (DEIA) in cardiovascular science and care. As a flagship of ASIDE Healthcare, the journal reflects these values in all activities and publications.

Our mission is to advance cardiovascular medicine by promoting innovative research, informed clinical practice, and transformative ideas that prioritize health equity. We amplify voices historically underrepresented in medical research and policy, and we publish work that challenges traditional narratives to foster a more inclusive, high-quality cardiovascular ecosystem.

Scope

ASIDE Cardiovascular publishes original research, systematic and narrative reviews, brief reports, clinical case studies, methods papers, and commentary across the heart–vascular spectrum, including (but not limited to):

  • Cardiology & Heart Failure, Interventional/Structural, Electrophysiology, Cardiac Imaging, Preventive/Lipid/Hypertension, Adult Congenital, Cardio-Oncology, Women’s Heart Health
  • Vascular Medicine & Surgery, Aortic & Peripheral Arterial Disease, Venous & Thromboembolic Disease
  • Cerebrovascular/Stroke interfaces, Cardiometabolic and Population Health, Implementation Science, Digital/Cardiac Devices & Remote Monitoring
    We particularly value work addressing social determinants of health, innovative care models for underserved populations, and interdisciplinary solutions.

Publication Frequency

Quarterly (four issues per year). Each issue contains peer-reviewed original research, reviews, case reports/series, and related scholarly content in cardiovascular medicine and vascular science.

Readership

Our readers include cardiologists, vascular specialists, surgeons, internists, imaging and EP teams, nurses and allied professionals, health-services researchers, policy makers, and educators worldwide, anyone dedicated to building a cardiovascular system that serves everyone.

Open Access & Licensing Policy

ASIDE Cardiovascular provides immediate open access to all content (no embargo, no registration).
Unless otherwise indicated, all articles are published under Creative Commons Attribution 4.0 International (CC BY 4.0). This license permits use, sharing, adaptation, distribution, and reproduction in any medium, including commercial use, provided appropriate credit is given, a link to the license is provided, and changes are indicated.
Authors retain copyright and grant the publisher a non-exclusive right of first publication under CC BY 4.0. The copyright holder and license appear on each article’s HTML and PDF.

Fees: The journal charges no submission or publication fees (no APCs).

Content (e.g., images, figures, data) not covered by CC BY 4.0 is identified by a credit line noting different terms; permission may be required for uses beyond those terms.

Editorial Process

We uphold a rigorous double-blind peer-review process managed by an international editorial board committed to scientific quality and to fairness, diversity, and inclusiveness in academic publishing. ASIDE Cardiovascular maintains editorial independence and does not accept advertising.

Direct Marketing Policy

We may send occasional, well-targeted calls for papers or informational messages aligned with our aims and scope. Outreach is truthful, unobtrusive, and compliant with applicable regulations (e.g., CAN-SPAM/GDPR). We do not guarantee acceptance, indexing, or publication outcomes, and we do not request or require payment as a condition of submission. Recipients can opt out at any time; unsubscribe requests are honored promptly. We do not buy third-party email lists.

 

Peer Review Policy (Double-Blind)

1) Introduction to Peer Review

What it is: Independent experts assess submissions for originality, validity, significance, and relevance.
Purpose at ASIDE Cardiovascular: To ensure published research is trustworthy and advances cardiovascular science and care.

2) Type of Peer Review

Double-blind: Authors and reviewers remain anonymous to minimize identity-related bias.

3) Double-Blind Process

  • Submission: Authors submit via the journal system and remove identifying information from manuscripts and supplements. Staff check scope and guideline compliance before review.
  • Reviewer Selection: Editors invite qualified experts based on subject expertise, prior review quality, and impartiality.
  • Conducting the Review: Reviewers evaluate significance, originality, methods, analysis, and presentation using predefined criteria; confidentiality is mandatory and conflicts must be declared.
  • Recommendations: Accept, minor revision, major revision, or reject—with constructive feedback.
  • Decisions: Editors synthesize reviewer input; if reviews conflict, additional opinions may be sought.
  • Revision & Re-review: Authors respond point-by-point; further rounds may occur.
  • Post-Acceptance: Copyediting, layout, proofs, and publication.

Why double-blind? To enhance impartiality and focus evaluation on scientific merit.
Integrity & fairness: Attempts to breach anonymity should be reported and will be addressed seriously.

 

Policies on Editorial Involvement and Endogeny

Conflicts for Editorial Members:
If the Editor-in-Chief, Associate Editor, or any editorial board member is an author on a submission, they must recuse themselves. A different qualified editor with no authorship role will manage the manuscript. Co-author editors have no access to the review workflow and no influence on the decision.

 

Ethical Standards

ASIDE Cardiovascular adheres to best-practice guidance from COPE, ICMJE, OASPA, and the Think. Check. Submit. initiative to ensure integrity, transparency, and fairness.

1) Editorial Standards

  • Integrity: We follow COPE/ICMJE guidance to maintain the scholarly record.
  • Fair Play: Manuscripts are judged for intellectual content only.
  • Confidentiality: Editorial information is disclosed only to those directly involved.

2) Duties of Reviewers

  • Contribution & Promptness: Decline if unqualified or unavailable.
  • Confidentiality & Objectivity: Reviews must be evidence-based and respectful.
  • Conflicts: Reviewers must disclose conflicts and recuse when needed.

3) Duties of Authors

  • Reporting Standards: Accurate work and objective discussion.
  • Data Access & Retention: Data available for review and, when possible, public access.
  • Originality & Citation: Proper citation; no redundant publication.
  • Authorship: Limited to those with substantial contributions.
  • Disclosures: Financial/substantive conflicts must be declared.

4) Publishing Ethics Issues

  • Monitoring: COPE-aligned handling of concerns and corrections.
  • Retractions: Issued when warranted by confirmed misconduct.

For journal selection best practices, authors are encouraged to consult Think. Check. Submit.
Contact: [email protected].

 

Preservation & Archiving Policy

ASIDE Cardiovascular is committed to long-term preservation and accessibility via:

  • PKP Preservation Network (PKP PN): Application submitted/maintained; upon activation, all published content is preserved automatically for OJS journals.
  • Internet Archive: Issues and PDFs are deposited in the Internet Archive (archive.org); core pages are periodically captured via the Wayback Machine.
  • Institutional/Library Repositories (Self-archiving): Authors are encouraged to deposit all versions—preprint, accepted manuscript, and version of record—without embargo.
  • OAI-PMH: Metadata and content are harvestable: https://asidejournals.com/index.php/cardiovascular/oai.

If the journal ceases publication, archived content remains permanently accessible via the Internet Archive and any active preservation services (e.g., PKP PN).

 

Repository & Self-Archiving Policy

Authors may deposit all versions of their articles in institutional, subject, funder, or personal repositories, and on academic profiles, without embargo:

  • Submitted version (preprint): any time.
  • Accepted version (AAM): immediately upon acceptance.
  • Published version (VoR): immediately upon publication.

Always include the full citation, DOI link to the Version of Record, and license. Articles are under CC BY 4.0. Journal metadata is harvestable via OAI-PMH: https://asidejournals.com/index.php/cardiovascular/oai.

 

Data Sharing & Reproducibility

We support open, reproducible research. All research articles must include a Data Availability Statement specifying where supporting data, code, and materials can be accessed (with persistent identifiers like DOIs when possible). For clinical trials, provide an ICMJE-compliant data-sharing statement.

  • Share underlying data (raw/processed), analysis code, protocols, and materials unless restricted by ethics, legal, or proprietary constraints; explain restrictions and controlled-access conditions where applicable.
  • Deposit datasets in trusted repositories—prefer domain repositories when available (e.g., GenBank, GEO); otherwise use generalist repositories that issue DOIs (e.g., Zenodo, Dryad, OSF). See re3data to locate repositories.
  • Host software/code in a public version-controlled repository (e.g., GitHub) and archive with a DOI (e.g., GitHub→Zenodo).
  • Prefer open, non-proprietary formats (e.g., CSV/TSV, JSON, TXT, PNG/TIFF) and provide documentation/metadata to make data FAIR (README, variable dictionary, license).
  • Human-participant data must be de-identified and shared per consent, IRB/ethics approvals, and applicable regulations. If data cannot be public, deposit metadata and specify controlled access.

Data and code should be available by acceptance and public at publication. Cite datasets/software (with DOIs) in references and include repository links in the Data Availability Statement.

 

Publisher Information

Publisher: American Society for Inclusion, Diversity, and Equity in Healthcare (ASIDE)
Registered Address: 16192 Coastal Highway, Lewes, Delaware 19958, USA
Country: United States of America
Publisher Website: https://www.asidehealthcare.org
Journals Portal: https://asidejournals.com
Contact: [email protected]